John Griese At the Address on file with the CompanyLetter Agreement • November 7th, 2022 • Cronos Group Inc. • Medicinal chemicals & botanical products • California
This letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), sets forth the terms and conditions of our agreement regarding the separation of your employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware (“CCS”), and Hortican Inc., a corporation organized under the federal laws of Canada (“Hortican), wholly owned subsidiaries of Cronos Group Inc., a corporation organized under the laws of the Province of British Columbia (“Cronos Group”). Unless context otherwise requires, capitalized terms used in this Letter Agreement that are not defined herein have the meanings set forth in your Employment Agreement with the CCS, dated as of January 10, 2022 (the “Employment Agreement”). For the avoidance of doubt, this Letter Agreement supersedes our letter dated October 18, 2022 regarding your separation from the Company.
Jeff Jacobson At the Address on file with the CompanyLetter Agreement • November 7th, 2022 • Cronos Group Inc. • Medicinal chemicals & botanical products
This letter agreement (this “Letter Agreement”), effective as of November 7, 2022 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your new position as Chief Growth Officer. Capitalized terms used in this Letter Agreement that are not defined herein have the meanings set forth in your employment agreement with Hortican Inc., a corporation organized under the federal laws of Canada (the “Company”), dated as of June 21, 2019 (the “Employment Agreement”).
